5 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Algorithm #AACE #2018 ... #Glycemic #Diabetes ... #DM2 #Control # ... Medication #Algorithm #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
Medications - AACE 2018 ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #comparison #management ... #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... Intraabdominal - Orthopedic ... Diabetes regimen ... PCI/DES ( Levine 2016 ... stroke ( Doherty 2017